CTMX logo

CytomX Therapeutics (CTMX) Company Overview

Profile

Full Name:

CytomX Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 8, 2015

Indexes:

Not included

Description:

CytomX Therapeutics (CTMX) is a biotechnology company focused on developing innovative cancer therapies. They use a unique technology called Probody™ to create treatments that target tumors while sparing healthy tissue, aiming to improve the effectiveness and safety of cancer treatments.

Key Details

Price

$0.70

Annual Revenue

$101.21 M(+90.38% YoY)

Annual EPS

-$0.01(+99.34% YoY)

Beta

0.58

Events Calendar

Earnings

Next earnings date:

Mar 11, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 11, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 7, 25 HC Wainwright & Co.
Neutral
Nov 11, 24 HC Wainwright & Co.
Neutral
Sep 13, 24 HC Wainwright & Co.
Neutral
Aug 22, 24 HC Wainwright & Co.
Neutral
Jun 27, 24 HC Wainwright & Co.
Neutral
May 28, 24 Piper Sandler
Overweight
May 9, 24 Wedbush
Outperform
May 9, 24 HC Wainwright & Co.
Neutral
May 9, 24 BMO Capital
Market Perform
May 6, 24 Jefferies
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for CytomX Therapeutics?
  • Does CytomX Therapeutics pay dividends?
  • What sector is CytomX Therapeutics in?
  • What industry is CytomX Therapeutics in?
  • What country is CytomX Therapeutics based in?
  • When did CytomX Therapeutics go public?
  • Is CytomX Therapeutics in the S&P 500?
  • Is CytomX Therapeutics in the NASDAQ 100?
  • Is CytomX Therapeutics in the Dow Jones?
  • When was CytomX Therapeutics's last earnings report?
  • When does CytomX Therapeutics report earnings?
  • Should I buy CytomX Therapeutics stock now?

What is the ticker symbol for CytomX Therapeutics?

The ticker symbol for CytomX Therapeutics is NASDAQ:CTMX

Does CytomX Therapeutics pay dividends?

No, CytomX Therapeutics does not pay dividends

What sector is CytomX Therapeutics in?

CytomX Therapeutics is in the Healthcare sector

What industry is CytomX Therapeutics in?

CytomX Therapeutics is in the Biotechnology industry

What country is CytomX Therapeutics based in?

CytomX Therapeutics is headquartered in United States

When did CytomX Therapeutics go public?

CytomX Therapeutics's initial public offering (IPO) was on October 8, 2015

Is CytomX Therapeutics in the S&P 500?

No, CytomX Therapeutics is not included in the S&P 500 index

Is CytomX Therapeutics in the NASDAQ 100?

No, CytomX Therapeutics is not included in the NASDAQ 100 index

Is CytomX Therapeutics in the Dow Jones?

No, CytomX Therapeutics is not included in the Dow Jones index

When was CytomX Therapeutics's last earnings report?

CytomX Therapeutics's most recent earnings report was on Nov 7, 2024

When does CytomX Therapeutics report earnings?

The next expected earnings date for CytomX Therapeutics is Mar 11, 2025

Should I buy CytomX Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions